A detailed history of Emfo, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Emfo, LLC holds 250 shares of LLY stock, worth $211,067. This represents 0.2% of its overall portfolio holdings.

Number of Shares
250
Previous 250 -0.0%
Holding current value
$211,067
Previous $194,000 16.49%
% of portfolio
0.2%
Previous 0.18%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 01, 2023

SELL
$434.7 - $599.3 $217,350 - $299,650
-500 Reduced 66.67%
250 $134,000
Q2 2023

Aug 03, 2023

SELL
$350.74 - $468.98 $526,110 - $703,470
-1,500 Reduced 66.67%
750 $351,000
Q1 2023

May 08, 2023

BUY
$310.63 - $364.82 $310,630 - $364,820
1,000 Added 80.0%
2,250 $772,000
Q3 2022

Oct 31, 2022

BUY
$296.48 - $337.87 $296,480 - $337,870
1,000 Added 400.0%
1,250 $404,000
Q3 2021

Oct 26, 2021

BUY
$221.6 - $272.71 $55,400 - $68,177
250 New
250 $58,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $802B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Emfo, LLC Portfolio

Follow Emfo, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Emfo, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Emfo, LLC with notifications on news.